Consortium > Associated Partner

Janssen Ireland

Contact person

Aoife Corcoran PhD

Johnson & Johnson has a long heritage in Ireland, dating back to 1935, and a large workforce of more than 6,000 people. Its Irish operations comprise both the Innovative Medicine and MedTech segments, making a significant contribution to the company’s global success with ten sites located in five counties (Cork, Dublin, Limerick, Galway and Mayo). Our Irish operations span research and development, manufacturing, shared services and country commercial businesses. At Johnson & Johnson Innovative Medicine, we’re committed to leading where medicine is going. We focus on tackling the toughest health challenges, particularly in areas of high patient need. Our research and development spans oncology, immunology, neuroscience, cardiopulmonary, and specialty ophthalmology, with a commitment to changing the standard of care, including evaluation of new drugs and therapeutic interventions that are personalised for optimised clinical outcomes.

Our team in Ringaskiddy, Cork, contributes to this work by providing end-to-end development and manufacturing support to our global biotherapeutics portfolio. Our state-of-the-art facility in Ringaskiddy, Cork opened in 2005 to develop innovative treatments for cancer and biomedicines for immune-related diseases, such as inflammatory bowel disease and psoriasis.

Aoife Corcoran is a Senior Manufacturing Team lead within the clinical and commercial manufacturing suite in Cork. Aoife was an Early-Stage Researcher in the Marie Sklodowska-Curie FP7-ITN “Decide”. She holds a PhD in Molecular Biology and Biochemistry from the University of Wrocław.

In eRaDicate, Janssen Ireland will provide secondment opportunities for the DCs, and provide training in job applications for large companies.